戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 and molecular layer interneurons (basket and stellate cells).
2 in the VCN, a projection neuron termed the D-stellate cell.
3 inergic cells in the VCN distinct from the D-stellate cell.
4 n of fibrosis-related genes in primary human stellate cells.
5 ular reaction, which were instead encased by stellate cells.
6 yclase (NO-GC), are expressed in somata of T-stellate cells.
7  fibroblasts, dermal fibroblasts and hepatic stellate cells.
8 ession suppresses MICA expression in hepatic stellate cells.
9 ic diseases and the activation of pancreatic stellate cells.
10 area, but over ten-fold more numerous than D-stellate cells.
11 y phenotype in pancreatic normal, cancer and stellate cells.
12 ctivates fibrosis-related markers in hepatic stellate cells.
13 ell as primary human hepatocytes and hepatic stellate cells.
14 s marker activation in primary human hepatic stellate cells.
15 (+) -dependent bile acid uptake mechanism in stellate cells.
16  only signalling in acinar cells but also in stellate cells.
17 n the overall bile acid uptake in pancreatic stellate cells.
18 ramidal cells were superimposed on scattered stellate cells.
19 asic effect on EPSC amplitudes recorded from stellate cells.
20 n mice, human hepatocytes, and human hepatic stellate cells.
21  osmotically obliged water flows through the stellate cells.
22  revealed a significant reduction in hepatic stellate cells.
23  in modulating the information processing of stellate cells.
24 R-induced AP threshold plasticity in AISs of stellate cells.
25 patocyte growth factor production by hepatic stellate cells.
26 lates the neuronal intrinsic excitability of stellate cells.
27 flammatory gene expression within pancreatic stellate cells.
28 vitamin A storage, resembled that of hepatic stellate cells.
29 t how dopamine modulates the function of MEC stellate cells.
30  lesions more likely contained predominantly stellate cells (6/14 [43%] vs 0/14 [0%]; P = .05) and fi
31                                           In stellate cells, a voltage-dependent increase in membrane
32 y liver disease activity scores, and hepatic stellate cell activation (alpha-smooth muscle actin) com
33 ic alphaSMA expression, a marker for hepatic stellate cell activation (r = -0.31, P < 0.02).
34 cided with alterations in markers of hepatic stellate cell activation and extracellular matrix remode
35 enefitted liver fibrosis via altered hepatic stellate cell activation and extracellular matrix remode
36 he activity of the PAR2 pepducin on cultured stellate cell activation and hepatocyte reactive oxygen
37 he dKO mice had similar levels of markers of stellate cell activation and matrix remodeling as Ppara(
38 nalicular formation and is needed to prevent stellate cell activation by modulating TGF-beta.
39 ally, LPI promoted the initiation of hepatic stellate cell activation by stimulating GPR55 and activa
40 usoidal endothelial cell capillarization and stellate cell activation demonstrates allograft injury i
41 C1QTNF2 expression is reduced during hepatic stellate cell activation in culture and in a mouse model
42             Vitamin A loss is accompanied by stellate cell activation in hepatic tissue.
43 osis and suppressed expression of markers of stellate cell activation in livers of mice fed a diet ri
44  Finally, MSDC-0602 directly reduced hepatic stellate cell activation in vitro, and MSDC-0602 treatme
45 ent or hepatocyte MPC2 deletion also limited stellate cell activation indirectly by affecting secreti
46                           FR reduced hepatic stellate cell activation markers (transforming growth fa
47            LOX inhibition attenuated hepatic stellate cell activation markers and promoted F4/80-posi
48 rentiation into polarized MPhis that mediate stellate cell activation via TGF-beta.
49                                      Hepatic stellate cell activation was detected by immunofluoresce
50 r sinusoidal endothelial cell activation and stellate cell activation was increased in patients with
51 tion of hepatic progenitor cell response and stellate cell activation, and normalization of liver enz
52 lting in hyperammonemia, evidence of hepatic stellate cell activation, and progressive fibrosis.
53             The activated macrophages caused stellate cell activation, leading to liver injury, by a
54 l protein adducts accompanied by evidence of stellate cell activation, matrix remodeling, and fibrosi
55 iated with hepatic progenitor cell features, stellate cell activation, NOTCH signaling, and an aggres
56                 Inhibiting IRE1alpha blocked stellate cell activation, which then decreased prolifera
57 iferation, senescence, fibrosis, and hepatic stellate cell activation, which were reduced in Hdc(-/-)
58  substrate stiffening resulted in attenuated stellate cell activation, with reduced YAP/TAZ nuclear s
59 tivation, prothrombin activation and hepatic stellate cell activation.
60 models of monocyte/macrophage and/or hepatic stellate cell activation.
61 vated monocytes/macrophages promoted hepatic stellate cell activation.
62 amine the relationship between retinoids and stellate cell activation.
63 owever, the molecular mechanisms for hepatic stellate-cell activation by HCV-infected hepatocytes are
64                 Furthermore, during licking, stellate cell activity was anisotropic: the coordination
65 se progression, and an increase in activated stellate cells after BDL in mice lacking iRhom2 (Rhbdf2(
66 y, is trapped in the basal infoldings of the stellate cells after kinin diuretic peptide stimulation,
67                            Activated hepatic stellate cell (aHSC)-mediated liver fibrosis is essentia
68                            Activated hepatic stellate cells (aHSCs) orchestrate scarring during liver
69 myofibroblastic phenotype (activated hepatic stellate cell; aHSCs) expressing smooth muscle alpha-act
70                          Addition of hepatic stellate cells allowed generation of myeloid-derived sup
71 etanercept reduced the presence of activated stellate cells and alleviated liver fibrosis after BDL.
72            Smooth-muscle actin expression by stellate cells and CD34 expression by liver sinusoidal e
73 in-1 (IL-1) receptor-dependent activation of stellate cells and endothelial cells, resulting in the t
74  secretory phenotype of quiescent pancreatic stellate cells and established an immunosuppressive mili
75 iculum (ER) stress in the cross-talk between stellate cells and HCC cells.
76 is an emerging new target expressed on liver stellate cells and hepatocytes that regulates the respon
77 ro experiments were performed in rat hepatic stellate cells and hepatocytes.
78 ression (LTD) between cortical layer 4 spiny stellate cells and layer 2/3 pyramidal cells requires th
79 aller fraction of NPs accumulated in hepatic stellate cells and liver sinusoidal endothelial cells, s
80 ls under normoxia and hypoxia, human hepatic stellate cells and LX2 cells, and xenograft tumors forme
81 e involvement of GATAe in the maintenance of stellate cells and migration of renal and nephritic stem
82 ct the tumor microenvironment by stimulating stellate cells and myeloid suppressors with TMZ-CD40L an
83 ractors for galectin-3 in live human hepatic stellate cells and peripheral blood mononuclear cells.
84 ting combined with RNA sequencing to isolate stellate cells and PMCs, and we identified determinants
85 xtracellular matrix and numbers of activated stellate cells and portal fibroblasts.
86  events, including the activation of hepatic stellate cells and regulation of immune responses.
87 othelial cell types as well as early hepatic stellate cells and reveal distinct spatiotemporal distri
88    We found that sGC is expressed in hepatic stellate cells and stellate-derived myofibroblasts, but
89 r escalated by bradykinin-induced signals in stellate cells and thus killing of stellate cells by bil
90 ECs (Liver Endothelial Cells), HSCs (Hepatic Stellate Cells) and/or myofibroblasts to mimic in vivo f
91 ssociation between macrophages and activated stellate cells, and a new potential role of tuft cells i
92 es in the majority of pyramidal cells, spiny stellate cells, and interneurons within the extrastriate
93  fibrogenic activation of attenuated hepatic stellate cells, and limits fibrosis reversal.
94 es, biliary epithelial cells, Kupffer cells, stellate cells, and liver sinusoidal endothelial cells e
95  They were activated by auditory nerve and T-stellate cells, and made local inhibitory synaptic conta
96 dothelin-induced vasoconstriction by hepatic stellate cells, and not platelet accumulation or coagula
97 etwork that includes macrophages, pancreatic stellate cells, and prominent cytokines that are present
98 a subset of TGF-beta target genes in hepatic stellate cells, and the cooperation between the JAK1-STA
99  reconstructions showed that NPY neurons are stellate cells, and the dendrites of NPY neurons in the
100  of interconnections could account for how T-stellate cells are able to encode spectral peaks over a
101 g of spectral peaks.SIGNIFICANCE STATEMENT T-stellate cells are interconnected through synapses that
102                                      Hepatic stellate cells are key players in the progression of HCC
103                                  Parenchymal stellate cells are the primary contributors to fibrosis
104 cinar cells but the effects of bile acids on stellate cells are unexplored.
105 ted excitatory synaptic responses, which, in stellate cells, are largely extrasynaptic, without a cha
106 arget of rapamycin, likely targeting hepatic stellate cells because differentiation and activation of
107                 Barrel cortex layer IV spiny stellate cells (bSCs) are the primary recipients of asce
108   Nitric oxide (NO) donors evoked EPSCs in T-stellate cells but not in the other types of principal c
109 pamine release increases the AP threshold of stellate cells by activating D2Rs.
110 ignals in stellate cells and thus killing of stellate cells by bile acids might have important implic
111 Early postnatally, layer-2 pyramidal but not stellate-cells co-localized with doublecortin - a marker
112                         In contrast, lack of stellate cell communication increases the regularity of
113 more dramatic Ca(2+) signals and necrosis in stellate cells compared to the adjacent acinar cells in
114 ectional and polysynaptic, indicating that T-stellate cells connect in networks.
115 arily potentiated interconnections between T-stellate cells could enhance the gain of auditory nerve
116 on of miR-200b in cholangiocytes and hepatic stellate cells decreased the expression of miR-200b, ang
117                               Hepatocyte and stellate cell deletion of liver fatty acid binding prote
118     The alignment of local collaterals and T-stellate cell dendrites within the isofrequency lamina s
119 flammation accompanied with elevated hepatic stellate cell-derived TnC and Toll-like receptor 4 expre
120 ivation of the autophagic pathway in hepatic stellate cells during Brucella infection could have an i
121                     The tonotopic array of T-stellate cells enhances the encoding of spectral peaks r
122               In vitro primary mouse hepatic stellate cells exhibited iRhom2-dependent shedding of th
123 rikingly, electrophysiological recordings in stellate cells from these PV-Cre/NL123 cKO mice revealed
124                                Compared with stellate cells, Gli1(+) PMCs expressed a different subse
125 ), which is secreted by activated pancreatic stellate cells, has important functions in chronic pancr
126 s that the Kupffer cell niche is composed of stellate cells, hepatocytes, and endothelial cells that
127 poptosis resistance in primary human hepatic stellate cells (hHSC).
128 anscriptome of rat PMFs, compared to hepatic stellate cell HSC-derived myofibroblasts in culture, ide
129 n of obeticholic acid (OCA) prevents hepatic stellate cell (HSC) activation and fibrogenesis.
130 yrosine kinases, which contribute to hepatic stellate cell (HSC) activation and liver fibrosis.
131                                      Hepatic stellate cell (HSC) activation and transforming growth f
132                                      Hepatic stellate cell (HSC) activation on liver injury facilitat
133 ternal stiffness is known to promote hepatic stellate cell (HSC) activation through mechanotransducti
134        We investigated mechanisms of hepatic stellate cell (HSC) activation, which contributes to liv
135 ould partly account for reduction of hepatic stellate cell (HSC) activation.
136  pathways included overexpression of hepatic stellate cell (HSC) activators such as fibronectin 1 (FN
137 on, LPC biliary differentiation, and hepatic stellate cell (HSC) chemotaxis.
138 onsequences of hepatocyte-macrophage-hepatic stellate cell (HSC) crosstalk.
139  beta-4 (TB4) involved in regulating hepatic stellate cell (HSC) functions remain unclear.
140 zebrafish liver in vivo and in human hepatic stellate cell (HSC) lines in culture activates fibrotic
141 ssion in the parenchymal hepatocyte, hepatic stellate cell (HSC), and the inflammatory compartments i
142 type 2 (CCR2) is expressed by active hepatic stellate cells (HSC) and is a key monocyte recruitment s
143 g the crosstalk of hepatocytes (HC), hepatic stellate cells (HSC) and liver sinusoidal endothelial ce
144                                      Hepatic stellate cells (HSC) are the major cellular contributors
145 iorates liver fibrosis by inhibiting hepatic stellate cells (HSC), and loss of miR-200a is associated
146 nse (UPR) both promote activation of hepatic stellate cells (HSC), however the link between the two s
147 incipally regulated by activation of hepatic stellate cells (HSC).
148 MLH) comprising primary macrophages, hepatic stellate cells (HSC, LX-2), and hepatocytes (Huh-7), per
149  (FAK) plays a key role in promoting hepatic stellate cells (HSCs) activation in vitro and liver fibr
150 cipally expressed in quiescent mouse hepatic stellate cells (HSCs) and directly suppressed production
151 nti-fibrotic effects of neratinib in hepatic stellate cells (HSCs) and in vivo models of CCl(4)-induc
152 ulate transcription, is expressed by hepatic stellate cells (HSCs) and is required for development of
153  liver fibrosis remission by killing hepatic stellate cells (HSCs) and producing interferon (IFN)-gam
154                                      Hepatic stellate cells (HSCs) are key players in the development
155  (SM alpha-actin) is up-regulated in hepatic stellate cells (HSCs) as they transition to myofibroblas
156 hesis that the NLRP3 inflammasome in hepatic stellate cells (HSCs) can directly regulate their activa
157                        Activation of hepatic stellate cells (HSCs) contributes to the development of
158  kinase receptor, is up-regulated in hepatic stellate cells (HSCs) during chronic liver injury.
159         Effects of LPS on fibrogenic hepatic stellate cells (HSCs) from WT and TLR4-KO mice were asse
160                                      Hepatic stellate cells (HSCs) have been identified as the main f
161                        Activation of hepatic stellate cells (HSCs) in response to injury is a key ste
162                                      Hepatic stellate cells (HSCs) induce hepatic inflammation and im
163                                      Hepatic stellate cells (HSCs) inhibit T cells, a process that co
164 Fbeta induces the differentiation of hepatic stellate cells (HSCs) into tumor-promoting myofibroblast
165                        Activation of hepatic stellate cells (HSCs) is a critical step in the developm
166               Rho kinase activity in hepatic stellate cells (HSCs) is associated with activation, tra
167 erating cholangiocytes and activated hepatic stellate cells (HSCs) participate in the promotion of li
168                                      Hepatic stellate cells (HSCs) play a major role increasing IHVR
169                                      Hepatic stellate cells (HSCs) play critical roles in liver fibro
170                    FXR activation in hepatic stellate cells (HSCs) reduces liver fibrosis (LF).
171                             Finally, hepatic stellate cells (HSCs) serve as a hub of intrahepatic sig
172 e demonstrated previously that mouse hepatic stellate cells (HSCs) suppress T cells via programmed de
173 rix proteins, such as collagen I, by hepatic stellate cells (HSCs) that culminates in cirrhosis.
174 hese secreted cytokines may activate hepatic stellate cells (HSCs) toward fibrosis.
175                                      Hepatic stellate cells (HSCs) were recently identified as liver-
176  increased LPA levels, activation of hepatic stellate cells (HSCs), and amplification of profibrotic
177 vity was detected in cholangiocytes, hepatic stellate cells (HSCs), and hepatocytes.
178 enic microenvironment, activation of hepatic stellate cells (HSCs), and progression of biliary fibros
179 liver disease is mostly displayed in hepatic stellate cells (HSCs), causing fibrosis/cirrhosis, and i
180                          In cultured hepatic stellate cells (HSCs), disrupting Hedgehog signaling blo
181 nt with activation and senescence of hepatic stellate cells (HSCs), exhibiting a senescence-associate
182 coholic steatohepatitis (NASH) using hepatic stellate cells (HSCs), hepatocytes, and mouse models of
183                            Activated hepatic stellate cells (HSCs), liver sinusoidal endothelial cell
184 directly targeting Gli3 in activated hepatic stellate cells (HSCs), reduces expression of Gli3 and pr
185 en promotes mechanical quiescence in hepatic stellate cells (HSCs), stromal fibroblast-like cells who
186 transcriptome signature of activated hepatic stellate cells (HSCs), the primary collagen-secreting ce
187                                      Hepatic stellate cells (HSCs), the primary mediators of fibrosis
188 tion (BDL) and in cultured activated hepatic stellate cells (HSCs), we show that OPN, besides being o
189 sm of this resistance by focusing on hepatic stellate cells (HSCs), which are known to regulate Treg
190 or beta (TGFbeta) potently activates hepatic stellate cells (HSCs), which promotes production and sec
191  cells (LSECs) promote quiescence of hepatic stellate cells (HSCs).
192 liferation and activation of resting hepatic stellate cells (HSCs).
193  fibrosis is marked by activation of hepatic stellate cells (HSCs).
194 elial neoplasia, or PDAC, as well as hepatic stellate cells (HSCs).
195 luding laminin (Ln)-332, produced by hepatic stellate cells (HSCs).
196  in cell lines of cholangiocytes and hepatic stellate cells (HSCs).
197 ing in enterocytes, hepatocytes, and hepatic stellate cells (HSCs).
198  from relay neurons in the thalamus to spiny stellate cells in layer 4 of the primary visual cortex (
199  cellular electrophysiological properties of stellate cells in layer II of MEC change systematically
200                                              Stellate cells in layer II of the mEC project to the hip
201 s in acinar cells, had only minor effects on stellate cells in lobules.
202                   Recordings from pairs of T-stellate cells in mice of both sexes revealed that firin
203  cells (NFkappaB) in hepatocytes and hepatic stellate cells in monoculture; however, they do not acco
204 uring pancreatic cancer cells and pancreatic stellate cells in multiple ratios to mimic variable tumo
205            Voltage clamp recordings from mEC stellate cells in rat brain slices showed that GTx inhib
206 tor function at parallel fibre synapses onto stellate cells in the cerebellum using whole-cell patch-
207                                              Stellate cells in the medial entorhinal cortex (MEC) are
208 duced fibrosis and the numbers of pancreatic stellate cells in the tumor stroma and altered the types
209 ly, RSCs do not replenish principal cells or stellate cells in the upper tubules.
210                                            T-stellate cells in the ventral cochlear nucleus (VCN) for
211 e major cerebellar neuroligin isoforms, from stellate cells in triple NL123 conditional knock-out mic
212  pathophysiological effects of bile acids on stellate cells in two experimental models: ex vivo (mous
213    This compound decreases the activation of stellate cells in vitro and in vivo, by reducing the lev
214 on of miR-200b in cholangiocytes and hepatic stellate cells in vitro, we evaluated angiogenesis and f
215 D3 expression, whereas endothelial cells and stellate cells induced LXR-alpha via a synergistic NOTCH
216 Cells showed decreased fibrogenesis, hepatic stellate cell infiltration, Kupffer cells and inflammato
217 t recruit neutrophils and convert pancreatic stellate cells into cancer-associated fibroblasts (CAFs)
218 pairment in inhibitory synaptic responses in stellate cells lacking NL123 despite a nearly complete s
219 olate induced cytosolic Ca(2+) elevations in stellate cells, larger than those elicited simultaneousl
220 lls (iPS-HPCs) and human iPS-derived hepatic stellate cell-like cells (iPS-HSCs).
221 , but not in co-culture with a human hepatic stellate cell line (LX-2) overexpressing LHX2.
222 involving the TRAIL receptors in the hepatic stellate cell line, LX2.
223 ulation; coculture of hepatocyte and hepatic stellate cell lines significantly increased expression o
224 fibrogenic program in hepatocyte and hepatic stellate cell lines through ROS, NFkappaB, and TGFbeta1
225                         Treatment of hepatic stellate cells (liver cells responsible for fibrosis) wi
226  tumor stroma had fewer activated pancreatic stellate cells, lower levels of periostin, and alteratio
227 med in vitro studies on immortalized hepatic stellate cells (LX-2).
228 f hepatocyte markers, oval cell markers, and stellate cell markers.
229 ate cultured fibroblasts and primary hepatic stellate cells (myofibroblast precursors in the liver) i
230  decreases neuronal excitability in layer II stellate cells of medial entorhinal cortex.
231 esponses in medial entorhinal cortical (MEC) stellate cells of rats, which express strong sub-thresho
232 but not under hyperpolarization, of layer II stellate cells of the MEC.
233 , mutation or RNAi-mediated knockdown in the stellate cells of the tubule of TAR2 (tyrR, CG7431) resu
234 ral cell types, including pancreatic acinar, stellate cells (PaSCs) and immune cells, SOCE is mediate
235  is likely that these neurons, here termed L-stellate cells, play a significant role in frequency-spe
236 tate transaminase, alanine transaminase, and stellate cell proliferation by up to 50-100%.
237         Recent findings implicate pancreatic stellate cells (PSC) as prominent mediators of inflammat
238            Conditioned media from pancreatic stellate cells (PSC), as well as from other fibroblasts,
239 ber 17 (SLC22A17) in human pancreatic cancer stellate cells (PSC), key mediators of the PDAC stroma.
240 oplasia, which is orchestrated by pancreatic stellate cells (PSCs) and accounts for the majority of t
241                     Activation of pancreatic stellate cells (PSCs) and consequent development of dens
242 rix proteoglycan overexpressed by pancreatic stellate cells (PSCs) and pancreatic ductal adenocarcino
243                                   Pancreatic stellate cells (PSCs) are key mediators in the productio
244                            Normal pancreatic stellate cells (PSCs) are regarded as quiescent, only to
245          Persistent activation of pancreatic stellate cells (PSCs) can perturb the biomechanical homo
246                                   Pancreatic stellate cells (PSCs) differentiate into cancer-associat
247                Differentiation of pancreatic stellate cells (PSCs) into myofibroblasts is inhibited b
248  activation of myofibroblast-like pancreatic stellate cells (PSCs) plays a predominant role in the fo
249 hen PC cells are co-cultured with pancreatic stellate cells (PSCs) they are significantly more resist
250 play a passive role in activating pancreatic stellate cells (PSCs) via recruitment of immune cells th
251 er of myofibroblasts or activated pancreatic stellate cells (PSCs)).
252 ng tumor-associated platelets and pancreatic stellate cells (PSCs), the two major players in the TME,
253 nalling between pancreatic acinar (PACs) and stellate cells (PSCs).
254 or olive glycinergic synapse, and the basket/stellate cell-Purkinje GABAergic synapse in the cerebell
255                              Contrary to the stellate cells, pyramidal cells show weaker temporal cod
256       During liver injury, quiescent hepatic stellate cells (qHSCs) transdifferentiate into prolifera
257 parate putative pyramidal cells and putative stellate cells recorded extracellularly in layer II of t
258 re killed by oncolysis, whereas infection of stellate cells reduced factors involved in stroma format
259 brosis, attenuated the activation of hepatic stellate cells, reduced frequencies of Th9, Th17 and Th1
260 ver, bile acid-elicited signalling events in stellate cells remain unexplored.
261 ut not putative dentate gyrus/CA3-projecting stellate cells, represented speed prospectively.
262    Yet by recording from axons of cerebellar stellate cell (SC) interneurons, we show that AP width v
263 ffer (KC), sinusoidal endothelial (LSEC) and stellate cells (SC) are major cellular components of the
264 s and the synaptic integrative properties of stellate cells (SCs) in the medial entorhinal cortex.
265 s (BCs) in the mouse cochlear nucleus with T-stellate cells (SCs), which do have normal overshooting
266 tigate Kv2 channel functions in mEC layer II stellate cells (SCs).
267                              Primary hepatic stellate cell-seeded hydrogels stiffened in situ at late
268 ctin mRNA), whereas EX increased the hepatic stellate cell senescence marker CCN1 (P < 0.01 vs. O-SED
269 ell types show phase precession but putative stellate cells show steeper slopes of phase precession a
270 ffects of neuroligin deletions on cerebellar stellate cell synapses by electrophysiology in acute sli
271 t cell synapses, but not at distal dendritic stellate cell synapses.
272            In addition, KCs activate hepatic stellate cells that are involved in liver fibrosis.
273 put image-based screen using primary hepatic stellate cells that identified the antifungal drug itrac
274  is a circulating factor produced by hepatic stellate cells that plays a critical role in vascular qu
275  active component) directly activate hepatic stellate cells, the fibrogenic cell in the liver, and dr
276 lize to opposite plasma membranes, and small stellate cells, the site of the chloride shunt conductan
277 we found that HCC-cells activate IREalpha in stellate cells, thereby contributing to their activation
278 ctly inhibiting the activation of pancreatic stellate cells, thereby reducing the deposition of extra
279 anism by which D2Rs modulate AP threshold of stellate cells through T-type Ca(2+) channels in MEC, in
280 iber (PF) to PC synapses and DSI at putative Stellate cell to PC synapses.
281 ivation of the autophagic pathway in hepatic stellate cells to create a microenvironment that promote
282 trol that could account for the ability of T-stellate cells to enhance the encoding of spectral peaks
283 aliciguat acted directly on isolated hepatic stellate cells to inhibit fibrotic and inflammatory sign
284 AIL pathway can mediate apoptosis of hepatic stellate cells to promote the resolution of liver fibros
285 proaches in mice, we compare how the lack of stellate cell versus basket cell GABAergic neurotransmis
286 DNA damage, whereas proliferation of hepatic stellate cells was stimulated by KCa3.1 inhibition.
287               By co-culturing HCC-cells with stellate cells, we found that HCC-cells activate IREalph
288  and as ammonia is known to activate hepatic stellate cells, we hypothesized that ammonia may be invo
289 howed that macrophages and activated hepatic stellate cells were the main cell types expressing PTX3
290 2 emerged around birth while reelin-positive stellate-cells were scattered throughout development.
291      The inflammatory cells activate hepatic stellate cells, which are the major source of myofibrobl
292 e can induce prolonged activation of hepatic stellate cells, which may result in liver fibrosis.
293 ADAM17-mediated shedding of TNFRs in hepatic stellate cells, which reduces TNFR signaling and liver f
294 d treatment caused necrosis predominantly in stellate cells, which was abolished by removal of extrac
295  and decreased the intrinsic excitability of stellate cells, which was caused by shifting rightward t
296                               Astrocytes are stellate cells whose appearance can resemble a pointed s
297  models have shown that targeting pancreatic stellate cells with all-trans-retinoic-acid (ATRA) repro
298                VIP neurons are glutamatergic stellate cells with sustained firing patterns.
299   We previously demonstrated that pancreatic stellate cells within pancreatic ductal adenocarcinoma (
300   Mechanistically, PTX3 mediated the hepatic stellate cell wound-healing response.

 
Page Top